RB1 and neoplasm: On the other hand, theadenoviral induction of a hypo-phosphorylated pRb variant resulted in tumorsuppression in WT pRb cell lines (Roig et al.,2004), demonstrating that pRb-based therapy should consider not justthe presence but also functionality of pRb in the tumor.